2021
DOI: 10.1016/j.jgar.2021.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 17 publications
0
7
0
Order By: Relevance
“…However, carbapenemase-producing K. pneumoniae was isolated in 1996, [ 22 ] and the strain is becoming a highly threatening pathogen, especially in a nosocomial setting. [ 23 ] Treatment options are extremely limited for these resistant strains, and infected patients have a higher mortality than those with a nonresistant strain. [ 24 ] At our institute, screening for such resistance was not routinely performed, so it is unknown whether these potentially resistant strains affect disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…However, carbapenemase-producing K. pneumoniae was isolated in 1996, [ 22 ] and the strain is becoming a highly threatening pathogen, especially in a nosocomial setting. [ 23 ] Treatment options are extremely limited for these resistant strains, and infected patients have a higher mortality than those with a nonresistant strain. [ 24 ] At our institute, screening for such resistance was not routinely performed, so it is unknown whether these potentially resistant strains affect disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…The clinical impact of CRE infections was diverse among patients from different regions. The 30-day all-cause mortality rate was higher in South America (28%) than in China (12-19.7%), the United States (23%), or Taiwan (23.2%) [26][27][28]. Despite there are geographic variations in the prognostic impact of CRE infections among general population, CRE infections lead to more signi cant impact among ICU patients.…”
Section: Discussionmentioning
confidence: 99%
“…The 30-day all-cause mortality rate was higher in South America (28%) than in China (12-19.7%), the United States (23%), or Taiwan (23.2%). [26][27][28] Despite there are geographic variations in the prognostic impact of CRE infections among general population, CRE infections lead to more significant impact among ICU patients. Among patients in the respiratory ICU, CRKP infections resulted in the in-hospital mortality rate up to 42.1%.…”
Section: Discussionmentioning
confidence: 99%
“…25 Moreover, CRE infections have resulted in substantial morbidity and mortality among hospitalized patients worldwide. [26][27][28] In the era of the increasing incidence of CRE infections, the clinical impact of the coexistence of CRE infections among hospitalized patients with CDI was not clear. The objective of this study is to investigate the risk factors and clinical impact of CRE infections among hospitalized patients with CDI.…”
Section: Introductionmentioning
confidence: 99%